PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+12.51%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.86B
AUM Growth
+$246M
(+15%)
Cap. Flow
+$92.3M
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
34.22%
Holding
1,158
New
69
Increased
498
Reduced
498
Closed
91
Top Buys
| 1 |
Apple
AAPL
|
+$14.3M |
| 2 |
Microsoft
MSFT
|
+$13.6M |
| 3 |
NVIDIA
NVDA
|
+$9.72M |
| 4 |
Tesla
TSLA
|
+$6.46M |
| 5 |
Amazon
AMZN
|
+$5.87M |
Top Sells
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$3.55M |
| 2 |
Fiserv
FI
|
+$3.33M |
| 3 |
Exxon Mobil
XOM
|
+$2.48M |
| 4 |
Chevron
CVX
|
+$2.02M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$1.23M |
Sector Composition
| 1 | Technology | 37.9% |
| 2 | Healthcare | 15.37% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Communication Services | 8.94% |
| 5 | Energy | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
International Flavors & Fragrances
IFF
$16.5B
| $563K | 0.03% |
7,070
+361
| +5% | +$28.7K |
|
477
Lucid Motors
LCID
$5.97B
| $560K | 0.03% |
8,131
+543
| +7% | +$37.4K |
|
|
CDMO
478
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $559K | 0.03% |
40,044
+4,069
| +11% | +$56.8K |
|
479
Agilent Technologies
A
$35.2B
| $559K | 0.03% |
4,651
+108
| +2% | +$13K |
|
480
Evergy
EVRG
$16.5B
| $558K | 0.03% |
9,560
-865
| -8% | -$50.5K |
|
481
Hubbell
HUBB
$23.5B
| $558K | 0.03% |
1,682
-157
| -9% | -$52.1K |
|
482
TransDigm Group
TDG
$72.5B
| $555K | 0.03% |
621
+55
| +10% | +$49.2K |
|
483
Alliant Energy
LNT
$16.4B
| $549K | 0.03% |
10,463
-943
| -8% | -$49.5K |
|
|
JKS
484
JinkoSolar
JKS
$1.26B
| $547K | 0.03% |
12,336
+1,129
| +10% | +$50.1K |
|
485
IDEAYA Biosciences
IDYA
$2.17B
| $547K | 0.03% |
23,272
-788
| -3% | -$18.5K |
|
486
Builders FirstSource
BLDR
$15.5B
| $547K | 0.03% |
4,021
-1,030
| -20% | -$140K |
|
487
Archer Daniels Midland
ADM
$29.5B
| $547K | 0.03% |
7,235
-14
| -0.2% | -$1.06K |
|
488
Mirum Pharmaceuticals
MIRM
$3.76B
| $546K | 0.03% |
21,116
+5,107
| +32% | +$132K |
|
489
RELX
RELX
$82.4B
| $546K | 0.03% |
16,334
-3,127
| -16% | -$105K |
|
490
Johnson Controls International
JCI
$70.5B
| $544K | 0.03% |
7,980
+640
| +9% | +$43.6K |
|
491
Biomea Fusion
BMEA
$109M
| $542K | 0.03% |
+24,713
| New | +$542K |
|
492
Sea Limited
SE
$114B
| $536K | 0.03% |
9,228
-777
| -8% | -$45.1K |
|
493
CRH
CRH
$74.7B
| $536K | 0.03% |
9,609
-1,838
| -16% | -$102K |
|
494
Gartner
IT
$17.6B
| $530K | 0.03% |
1,514
+388
| +34% | +$136K |
|
495
CommScope
COMM
$3.59B
| $529K | 0.03% |
94,029
+29,177
| +45% | +$164K |
|
496
Bank of New York Mellon
BK
$73.3B
| $529K | 0.03% |
11,874
-1,194
| -9% | -$53.2K |
|
497
Constellation Brands
STZ
$25.2B
| $528K | 0.03% |
2,147
-10
| -0.5% | -$2.46K |
|
498
CareDx
CDNA
$710M
| $526K | 0.03% |
61,920
-13,097
| -17% | -$111K |
|
499
Zai Lab
ZLAB
$3.16B
| $523K | 0.03% |
18,848
-2,302
| -11% | -$63.8K |
|
500
4D Molecular Therapeutics
FDMT
$324M
| $520K | 0.03% |
28,779
+3,700
| +15% | +$66.9K |
|